Published in J Neural Transm (Vienna) on January 01, 1998
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci (2005) 1.55
Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease. Neural Regen Res (2015) 1.47
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology (2008) 1.41
Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res (2008) 1.38
Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol (2001) 1.37
Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol (2002) 1.26
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal (2013) 1.20
A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes (2010) 1.17
Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement (2013) 1.13
Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology (2014) 1.10
Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease. PLoS One (2012) 1.01
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev (2011) 1.00
Actions of β-amyloid protein on human neurons are expressed through the amylin receptor. Am J Pathol (2010) 0.97
A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose. Biochem J (2003) 0.96
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother (2010) 0.93
Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br J Pharmacol (2012) 0.92
Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis. Am J Pathol (2003) 0.92
Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways. J Neural Transm (Vienna) (2012) 0.91
Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators Inflamm (2015) 0.89
Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker. J Diabetes Metab Disord (2014) 0.88
Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. Biomed Res Int (2014) 0.87
Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.85
Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol Sin (2011) 0.83
Factors associated for mild cognitive impairment in older korean adults with type 2 diabetes mellitus. Diabetes Metab J (2014) 0.82
The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother (2011) 0.82
Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam. Front Neurosci (2010) 0.81
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm (Vienna) (2006) 0.80
Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity. PLoS One (2011) 0.79
Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype. Acta Neuropathol Commun (2016) 0.79
Stem cell treatment for Alzheimer's disease. Int J Mol Sci (2014) 0.78
Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel neuroprotective genes. J Neural Transm (Vienna) (2013) 0.77
Therapeutic Effect of Yi-Chi-Tsung-Ming-Tang on Amyloid β-Induced Alzheimer's Disease-Like Phenotype via an Increase of Acetylcholine and Decrease of Amyloid β. Evid Based Complement Alternat Med (2012) 0.77
Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol Neurobiol (2015) 0.77
Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna) (2008) 0.76
Medicinal Plants of the Australian Aboriginal Dharawal People Exhibiting Anti-Inflammatory Activity. Evid Based Complement Alternat Med (2016) 0.75
Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms. Eur Neuropsychopharmacol (2014) 0.75
Metabolic changes may precede proteostatic dysfunction in a Drosophila model of amyloid beta peptide toxicity. Neurobiol Aging (2016) 0.75
Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation. J Biomed Sci (2017) 0.75
Synthesis of hexose-related imidazolidinones: novel glycation products in the Maillard reaction. Glycoconj J (1999) 0.75
Quantum dots for live cells, in vivo imaging, and diagnostics. Science (2005) 21.62
Simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A (1984) 7.76
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med (1988) 7.22
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA (1996) 5.31
Ultrastructure of the yeast actin cytoskeleton and its association with the plasma membrane. J Cell Biol (1994) 5.14
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet (1995) 4.31
Initiation of simian virus 40 DNA replication in vitro: large-tumor-antigen- and origin-dependent unwinding of the template. Proc Natl Acad Sci U S A (1987) 4.23
Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell (2001) 4.21
The impact of role models on medical students. J Gen Intern Med (1997) 3.99
Cyclin-dependent kinases prevent DNA re-replication through multiple mechanisms. Nature (2001) 3.98
New ages for the last Australian megafauna: continent-wide extinction about 46,000 years ago. Science (2001) 3.91
Simian virus 40 DNA replication in vitro: specificity of initiation and evidence for bidirectional replication. Mol Cell Biol (1985) 3.84
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81
Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology (2007) 3.73
Multidimensional model of racial identity: a reconceptualization of African American racial identity. Pers Soc Psychol Rev (1998) 3.54
Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging (2001) 3.48
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A (1997) 3.47
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res (1997) 3.41
Functional organization of the simian virus 40 origin of DNA replication. Mol Cell Biol (1986) 3.40
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science (1986) 3.36
The family health worker. Am J Public Health Nations Health (1968) 3.34
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25
Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A (1987) 3.21
Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med (1984) 3.14
HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet (1992) 3.09
Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci (1997) 3.08
Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem (1992) 3.06
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A (1987) 2.97
Projected costs of ischemic stroke in the United States. Neurology (2006) 2.93
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91
Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med (1994) 2.90
Women prefer hospital births. BMJ (1992) 2.88
Experiences in Hong Kong with the theory and practice of the albumin column method of sperm separation for sex selection. Hum Reprod (1998) 2.87
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature (1997) 2.86
Identification of cellular proteins required for simian virus 40 DNA replication. J Biol Chem (1989) 2.84
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem (1997) 2.80
Kaposi's sarcoma in HIV-negative homosexual men. Lancet (1990) 2.80
Cachectin/tumour necrosis factor. Lancet (1989) 2.77
Energy efficient medium access protocol for wireless medical body area sensor networks. IEEE Trans Biomed Circuits Syst (2008) 2.75
Late mortality after surgery for peptic ulcer. N Engl J Med (1982) 2.73
Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging (1997) 2.69
A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia (2013) 2.63
Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol (1997) 2.56
Oxidative damage in Alzheimer's. Nature (1996) 2.55
Ricinoleic acid biosynthesis and triacylglycerol assembly in microsomal preparations from developing castor-bean (Ricinus communis) endosperm. Biochem J (1991) 2.53
Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A (1997) 2.53
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med (1989) 2.52
Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci (2000) 2.52
Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A (1999) 2.43
Direction of reading of the genetic message. J Biol Chem (1965) 2.43
Functional interchangeability of DNA replication genes in Salmonella typhimurium and Escherichia coli demonstrated by a general complementation procedure. Genetics (1984) 2.42
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol (1996) 2.36
Serum transaminases during salicylate therapy. Br Med J (1971) 2.34
Radical AGEing in Alzheimer's disease. Trends Neurosci (1995) 2.32
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
The rational clinical examination. Does this patient have strep throat? JAMA (2000) 2.30
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett (1994) 2.27
The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway. Genes Dev (1997) 2.26
Multiple shunt failures: an analysis of relevant factors. Childs Nerv Syst (1998) 2.25
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Clb/Cdc28 kinases promote nuclear export of the replication initiator proteins Mcm2-7. Curr Biol (2000) 2.23
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett (1995) 2.19
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A (1990) 2.18
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med (1995) 2.17
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett (1994) 2.17
Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem (1990) 2.16
A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol (1988) 2.14
Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur J Ageing (2013) 2.12
Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol (1987) 2.11
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci U S A (1985) 2.11
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med (1995) 2.10
Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10
Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.09
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol (1989) 2.07
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med (1995) 2.07
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04
Ancient hematoma: a unifying concept for a post-traumatic lesion mimicking an aggressive soft tissue neoplasm. Mod Pathol (1997) 2.04
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
Arginine deiminase system and bacterial adaptation to acid environments. Appl Environ Microbiol (1987) 2.03
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A (1993) 2.00